Glaxosmithkline Australia Pty Ltd.
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Salbutamol Sulfate Inhalation Solution
- Product Name
- 万托林
- Approval Number
- 国药准字HJ20160660
- Approval Date
- Nov 2, 2021
NMPA
Fluticasone Propionate Inhalation Aerosol
- Product Name
- 辅舒酮
- Approval Number
- H20130190
- Approval Date
- Dec 27, 2019
NMPA
Fluticasone Propionate Inhalation Aerosol
- Product Name
- 辅舒酮
- Approval Number
- H20130189
- Approval Date
- Dec 27, 2019
NMPA
Salbutamol Sulphate Inhalation Aerosol
- Product Name
- 硫酸沙丁胺醇吸入气雾剂
- Approval Number
- 国药准字J20160074
- Approval Date
- Sep 18, 2016
NMPA
Salbutamol Sulfate Inhalation Aerosol
- Product Name
- 硫酸沙丁胺醇吸入气雾剂
- Approval Number
- H20150674
- Approval Date
- Dec 10, 2015
NMPA
Clinical Trials
No trials found
News
No news found